Latest From Scrip Team
Pipeline Watch: Six Approvals And 12 Phase III Readouts
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Executives On The Move: Viracta Therapeutics Acquires Chief Fincancial Officer From Harpoon
Recent moves in the industry include new chief scientific officer at Wave Life Sciences, while Alliance Pharma gets a new CEO.
Pipeline Watch: Five Approvals And 13 Phase III Readouts
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Executives On The Move: Senior Moves At ALX Oncology, Aprea And PDS
Recent moves in the industry include new CEOs at Juno Pharmaceuticals and YS Biopharma, plus Glenmark gets a new chief communications officer.
Pipeline Watch: Six Approvals And 13 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Executives On The Move: Senior Moves At Innovent Biologics, Actym Therapeutics And Enanta Pharmaceuticals
Recent moves in the industry also include C-suite shuffles at Faron Pharmaceuticals and new chief financial officers at Orion, BioVaxys Technology and Cullinan Therapeutics.